Life Extension Magazine®

Block Absorption of Killer Carbohydrates

An estimated 60 million American adults suffer from abnormally high blood sugar—a pre-diabetic state that can sharply increase degenerative disease risk. Many of these people have lost their metabolic capacity to process even a low carbohydrate diet. A novel group of natural carbohydrate enzyme-inhibitors offers aging individuals a practical way to control glucose levels, improve blood markers of health, and regain glycemic balance.

Scientifically reviewed by: Dr. Gary Gonzalez, MD, in August 2023. Written by: Julius Goepp, MD.

Block Absorption of Killer Carbohydrates

If you’re an American over 20 years old, you may already suffer from some form of impaired glucose control.

According to 2007 data from the National Institutes of Health, 25% of Americans 20 years and older had abnormally high levels of glucose in the blood—a pre-diabetic state. That number leapt to 35% in individuals 60 and older. Extrapolating from the total US population, nearly 60 million American adults may now be pre-diabetic.1

These statistics make it clear that the glut of excess carbohydrate calories lurking in the Western diet undermines our best efforts to maintain healthy metabolic function and body weight.

Far too many people have lost their metabolic capacity to properly process carbohydrates. The result is a looming public health disaster, as impaired glucose control initiates a series of metabolic disorders that sharply increases disease risk.

To reverse this lethal epidemic of impaired glucose control, aging individuals often require more aggressive measures than merely limiting carbohydrate intake.

Fortunately, researchers have discovered proven methods to limit one’s exposure to carbohydrate calories without dramatic changes in diet. It centers on a group of natural compounds called enzyme inhibitors.

These interventions block the action of sucrase, amylase, and glucosidase, digestive enzymes responsible for the breakdown of various forms of carbohydrate. Instead of absorbing and converting these sugars into higher than desired blood glucose levels, you may be able to safely eliminate many of these excess carbohydrate calories.

These natural “carb-blockers” provide a practical approach to help lower glucose levels, improve age-related markers of health, and regain glycemic control.2

Combating the Scourge of Sucrose

Starting in early childhood, most Americans are exposed to far too much refined carbohydrates in the form of sucrose (table sugar). It is virtually omni-present in processed foods. It also happens to be an enemy to human health and an age-accelerator.

Many individuals do not even knowingly ingest it. According to a 2009 study in the Journal of Nutrition, only 3% of dietary sucrose is deliberately added by consumers; 82% is added by manufacturers.3 And while the World Health Organization (WHO) recommends that sucrose comprise only 10% of total energy intake, many people substantially exceed this level from the earliest years of life—usually at the expense of key nutrients.3,4

Combating the Scourge of Sucrose

Manufacturers know that most people will consistently choose sweetened over unsweetened foods and beverages.5 People will often continue to do so at the expense of their own health. After years of chronic exposure to sucrose, physiological processes not unlike addiction take hold. Rapid absorption of sugars from a high-sucrose meal triggers a dangerous sequence of unfavorable hormonal and metabolic alterations that promote still greater consumption, especially in overweight individuals.6,7 The result is the dangerously high incidence of metabolic disease we see today—obesity, type 2 diabetes, and metabolic syndrome.8-10

This alarming trend has led to a set of novel, evidence-based solutions. Aging individuals now have practical means at their disposal to slow or reverse the long-term consequences of chronic sucrose overexposure.

Sucrose is composed of two simple sugar molecules, glucose and fructose. It is poorly absorbed in the intestine in this form. In order to be utilized, it must first be broken down by the digestive enzyme sucrase. Blocking the enzymatic action of sucrase therefore limits uptake of sucrose.


Researchers have identified a potent sucrase inhibitor called L-arabinose. Although it is a simple plant sugar, L-arabinose is indigestible and cannot be absorbed into the blood. Instead it remains in the digestive tract and is eventually excreted.11,12 By blocking metabolism of sucrose, L-arabinose inhibits the spike in blood sugar and fat synthesis that would otherwise follow a sugar-rich meal.12 In animal models, L-arabinose virtually eliminates the rise in blood sugar following administration of sucrose, with blood glucose levels rising only 2% higher than in control animals that did not receive sucrose. L-arabinose did not exert any effect on serum glucose levels in control animals that did not receive sucrose.13

L-arabinose has been proven safe in both short- and long-term studies, and may contribute to lowered levels of glycosylated hemoglobin (hemoglobin A1C),14 a measure of chronic exposure to sugar in the blood. A study combining L-arabinose and white bean extract (see next page) not only smoothed out postprandial glucose spikes and reduced insulin levels—it lowered systolic blood pressure.14


The trace element chromium is another potent aid in the management of healthy blood sugar levels. Scientists have known for years that chromium aids in the management of type 2 diabetes, where it not only helps control blood glucose but also reduces total cholesterol levels.15-17 The combination of chromium with L-arabinose attacks multiple targets to prevent sucrose-induced blood sugar elevation and reduce sugar calorie exposure.

Complex Carbohydrate Enzyme Inhibitors

White Bean Extract

Extracts from the common white kidney bean, Phaseolus vulgaris, are powerful blockers of the enzyme alpha-amylase, which is secreted by the pancreas.18,19 Alpha-amylase breaks down long-chain, complex starch molecules into simple sugars and short-chain oligosaccharides for absorption in the small intestine. Blocking alpha-amylase inhibits the metabolism of starches and slows the rate at which free sugars are absorbed.

White bean extract shows enormous potential for preventing the blood sugar and insulin spikes that are associated with many chronic health disorders.13 Slowing starch digestion also prolongs the amount of time it takes for the stomach to empty its contents, further reducing the amount of carbohydrate calories released at any one time into the intestine.20

White bean extracts operate along numerous overlapping pathways in multiple, related physiological systems. Laboratory research shows that supplementation with white bean extract promotes weight loss in obese animals, with dramatic reduction in fat accumulation without loss of muscle mass.21,22 Plasma insulin levels also dropped substantially following a high-carbohydrate meal including white bean extract in pre-clinical studies, reflecting a much more gradual rise in blood sugar levels.22

Amylase inhibition with white bean extract has proven particularly effective in reducing glycemia (sugar load in the blood) in studies on diabetic animals. Supplementation in diabetic rats not only substantially lowered mean blood sugar levels; it also reduced the animals’ total food and water intake (water intake is increased in untreated diabetes because of the amount lost in sugar-laden urine).23 White bean extract has also been shown to boost levels of an intestinal hormone called cholecystokinin (CCK), which produces the sensation of satiety following a meal and reduces the urge to continue eating.24 Research further indicates it can restore overactive intestinal sugar-digesting enzymes to nearly normal levels, further reducing the sugar load.23

What You Need to Know: Irvingia
  • Roughly 1 in 5 Americans are pre-diabetic, a result of excess carbohydrate consumption.
  • The digestive enzymes sucrase, amylase, and glucosidase are primarily responsible for enabling carbohydrate absorption into the blood.
  • L-arabinose—a natural but largely indigestible sugar—blocks sucrase activity, preventing the sugar sucrose from entering the bloodstream.
  • Extracts of white bean, seaweed, and Irvingia block the breakdown of starch in the intestine, preventing their calories from being absorbed.
  • Green tea extract helps your body burn additional calories at rest.
  • Collectively, these natural compounds may dramatically inhibit total carbohydrate intake, limit postprandial blood sugar and insulin spikes, and generate weight loss.

White bean extract has yielded equally compelling results in human studies. It has been shown to diminish the effects of high-glycemic index foods (like white bread) that are notorious for producing sharp, potentially dangerous postprandial blood sugar spikes, helping to alleviate metabolic burden throughout the body.25 In obese but otherwise healthy patients, supplementation with white bean extract produces weight loss more than twice as fast as in controls.26 Even in people who are only slightly overweight, white bean extract reduces body weight, body mass index (BMI), fat mass, fat tissue thickness, and waist circumference, while maintaining lean body mass27—key elements that are linked with metabolic syndrome and cardiovascular disease risk.

What You Need to Know: Irvingia

White bean extract is highly effective even in aging individuals whose diets contain the highest amounts of carbohydrates.28 By blocking amylase and slowing starch digestion, it increases the amount of intact carbohydrates reaching the lower bowel, where they are consumed by beneficial intestinal bacteria.19 It has also been shown to induce a three-fold reduction in serum triglycerides compared to controls.26

White bean extract has an excellent safety profile, even at high doses.29 As with all the carbohydrate inhibitors reviewed here, it does not reduce blood sugar to below normal levels—an important feature for diabetics in whom large swings in glucose levels are especially dangerous.13

It should be noted that ingestion of white bean extract may result in minor intestinal protein losses, requiring additional protein intake.30


Extract of the wild African mango Irvingia gabonensis can produce weight loss by inhibiting calorie absorption and storage through multiple mechanisms. It also exerts potent anti-diabetic and anti-obesity effects.31 Studies from Africa in the mid-1980’s showed that Irvingia extract normalized blood sugar in diabetic patients while increasing the activity of enzymes involved in cellular energy metabolism.32 Irvingia extract also lowers blood levels of dangerous LDL and VLDL in diabetics, while increasing beneficial HDL levels.33 It mobilizes liver enzyme activity in favor of glucose storage and away from its release into the bloodstream, thereby improving glucose control.31

Irvingia works in part by inhibiting the amylase enzyme, and thus provides support for those attempting to restrict their total carbohydrate exposure and lose weight.31 In one double-blind, placebo-controlled study of obese but otherwise healthy adults, one month of supplementation produced a 5.3% body weight loss in supplemented patients, compared with only a 1.3% loss in the control group.34 These individuals also saw significant improvement in their lipid profiles. Additional studies confirm these findings, demonstrating significant reductions in body fat content, waist circumference, blood sugar levels, and markers of fat tissue regulation.35,36

White bean extract... has been shown to diminish the effects of high-glycemic index foods that produce sharp, potentially dangerous postprandial blood sugar spikes.

In addition to blocking amylase activity, Irvingia extract acts directly on fat cells to reduce lipid formation and storage.31,37 Its operation is multi-modal—downregulating genes that promote fat production—while upregulating factors that suppress it, including adiponectin,36,37 a glucose-regulating hormone that lowers fat-mediated inflammation and enhances insulin sensitivity.38 Adiponectin levels correlate with a reduction in risk for metabolic syndrome.39,40

Seaweed Extracts

Extracts from several seaweed species (actually the complex algae known as kelp) are potent inhibitors of amylase and another digestive enzyme called alpha-glucosidase. They have proven to be cost-effective means of preventing the progression of diabetes in pre-clinical models.41 In particular, extracts of Fucus vesiculosus and Ascophyllum nodosum are known to help lower blood glucose in normal and diabetic animals.42,43

A recent detailed study of a seaweed compound containing extracts from both Fucus and Ascophyllum offers insights into their mechanisms and benefits. The combination was given to laboratory rats prior to a meal with a high glycemic index.44 Such meals typically produce a rapid rise in both glucose and insulin levels in the blood, with an equally rapid drop within 60 minutes. The glucose spike contributes to excessive formation of dangerous advanced glycation end-products (AGEs). The insulin spike contributes to paradoxically low blood sugar at about 90 minutes, which can create a sensation of hunger, prompting excess food consumption.

The seaweed combination cut postprandial sugar spikes by 90% compared with untreated animals.44 That in turn reduced the insulin spike by 40%, which completely eliminated the period of low blood sugar that followed the meal in untreated rats.

In response to this seaweed combination, postprandial glucose and insulin profiles were modified to levels resembling meals with a much lower glycemic load. Blood sugar rose more slowly, achieved a shorter and more modest peak level, and then declined more gradually without ever “bottoming out” at an abnormally low level.

A recently completed human clinical trial produced similarly promising results. In this randomized, crossover, placebo-controlled, double-blind study conducted at Laval University, 23 healthy volunteers consumed 500 mg of a Fucus-Ascophyllum combination along with a high-glycemic index meal of white bread. The seaweed combination produced a 44% reduction in the glycemic response that normally follows ingestion of such a meal. The seaweed combination also produced a 22% reduction in the initial insulin production following the meal, and an overall 5.9% reduction in the area under the curve of the insulin response. The study results will be presented at the Experimental Biology meeting in Anaheim in April, 2010.45

The findings suggest that in humans, the Fucus-Ascophyllum compound may lead to earlier satiety, longer intervals between meals, fewer urges to snack, and lower total calorie intake.

Green Tea Extract

Raising basal metabolic rate is another effective mechanism for offsetting excess carbohydrate intake. Green tea extract boosts the “resting” metabolism by inhibiting an enzyme called catechol-O-methyl transferase or COMT that breaks down noradrenaline, an adrenaline-like hormone that sustains energy production.55 The resulting higher levels of metabolic activity help to burn off excess calories.56

In a large clinical trial, a patented green tea phytosome extract produced exceptional weight loss in obese individuals. Supplemented subjects lost almost 31 lbs over 3 months, while controls lost just 11 pounds!57 Both groups followed a low calorie diet. Multiple studies of overweight and obese adults indicate that green tea extracts can reduce abdominal fat as well as total cholesterol, LDL, and fasting triglyceride levels.58,59

Green tea provides another benefit in helping to alleviate the metabolic burden imposed by excess calorie ingestion. It has been shown to inhibit the lipase digestive enzyme that breaks down dietary fats for absorption into the blood.60


Roughly 1 in 5 Americans are pre-diabetic, a result of excess calorie consumption and normal aging. Sucrase, amylase, and glucosidase are digestive enzymes that break down carbohydrates, and lipase is a digestive enzyme that breaks down fat, facilitating absorption of excess calories into the blood.

As humans age, the impact of chronic caloric overload enabled by these digestive enzymes can lead to an array of life-threatening conditions ranging from high blood sugar and insulin to type 2 diabetes, obesity, and metabolic syndrome.

Natural compounds have been shown to effectively inhibit these digestive enzymes and impede the absorption of excess carbohydrate. L-arabinose neutralizes sucrase, reducing uptake of sugar (as sucrose) into the blood. Extracts of white bean, Irvingia gabonensis, and certain seaweeds block amylase and glucosidase activity, further reducing the number of ingested carbohydrate calories that are absorbed. Green or black tea extract can help reduce the activity of lipase, a digestive enzyme that helps break down fat in the gastrointestinal tract.

These natural compounds have been shown to effectively lower excess calorie absorption while reducing postprandial (post-meal) blood sugar and blood fat (triglyceride) spikes.

If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.


1. Available at: Accessed November 30, 2009.

2. Bischoff H. Pharmacology of alpha-glucosidase inhibition. Eur J Clin Invest. 1994 Aug;24 Suppl 3:3-10.

3. Erkkola M, Kronberg-Kippila C, Kyttala P, et al. Sucrose in the diet of 3-year-old Finnish children: sources, determinants and impact on food and nutrient intake. Br J Nutr. 2009 Apr;101(8):1209-17.

4. Ruottinen S, Niinikoski H, Lagstrom H, et al. High sucrose intake is associated with poor quality of diet and growth between 13 months and 9 years of age: the special Turku Coronary Risk Factor Intervention Project. Pediatrics.2008 Jun;121(6):e1676-85.

5. Vorster HH, van Tonder E, Kotze JP, Walker AR. Effects of graded sucrose additions on taste preference, acceptability, glycemic index, and insulin response to butter beans. Am J Clin Nutr. 1987 Mar;45(3):575-9.

6. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics.1999 Mar;103(3):E26.

7. Van Wymelbeke V, Beridot-Therond ME, de La Gueronniere V, Fantino M. Influence of repeated consumption of beverages containing sucrose or intense sweeteners on food intake. Eur J Clin Nutr. 2004 Jan;58(1):154-61.

8. Striegel-Moore RH, Thompson D, Affenito SG, et al. Correlates of beverage intake in adolescent girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2006 Feb;148(2):183-7.

9. Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med. 2008 Jul 28;168(14):1487-92.

10. Culling KS, Neil HA, Gilbert M, Frayn KN. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects. Nutr Metab Cardiovasc Dis. 2009 Jun;19(5):345-51.

11. Seri K, Sanai K, Matsuo N, Kawakubo K, Xue C, Inoue S. L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism. 1996 Nov;45(11):1368-74.

12. Osaki S, Kimura T, Sugimoto T, Hizukuri S, Iritani N. L-arabinose feeding prevents increases due to dietary sucrose in lipogenic enzymes and triacylglycerol levels in rats. J Nutr. 2001 Mar;131(3):796-9.

13. Preuss HG, Echard B, Bagchi D, Stohs S. Inhibition by natural dietary substances of gastrointestinal absorption of starch and sucrose in rats and pigs: 1. Acute studies. Int J Med Sci. 2007;4(4):196-202.

14. Preuss HG, Echard B, Bagchi D, Stohs S. Inhibition by natural dietary substances of gastrointestinal absorption of starch and sucrose in rats 2. Subchronic studies. Int J Med Sci. 2007;4(4):209-15.

15. Terpilowska S, Zaporowska H. The role of chromium in cell biology and medicine. Przegl Lek. 2004;61 Suppl 3:51-4.

16. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus—a review. Diabetes Technol Ther. Dec 2006 Dec;8(6):677-87.

17. Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007 Aug;30(8):2154-63.

18. Mosca M, Boniglia C, Carratu B, Giammarioli S, Nera V, Sanzini E. Determination of alpha-amylase inhibitor activity of phaseolamin from kidney bean (Phaseolus vulgaris) in dietary supplements by HPAEC-PAD. Anal Chim Acta. 2008 Jun 9;617(1-2):192-5.

19. Obiro WC, Zhang T, Jiang B. The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor. Br J Nutr. 2008 Jul;100(1):1-12.

20. Layer P, Zinsmeister AR, DiMagno EP. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology.1986 Jul;91(1):41-8.

21. Santoro LG, Grant G, Pusztai A. Effects of short-term feeding of rats with a highly purified phaseolin preparation. Plant Foods Hum Nutr. 1997;51(1):61-70.

22. Pusztai A, Grant G, Buchan WC, Bardocz S, de Carvalho AF, Ewen SW. Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean (Phaseolus vulgaris) in the diet.

Br J Nutr. 1998 Feb;79(2):213-21.

23. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE. White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. Br J Nutr. 2006 Sep;96(3):539-44.

24. Fantini N, Cabras C, Lobina C, et al. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem. 2009 Oct 14;57(19):9316-23.

25. Udani JK, Singh BB, Barrett ML, Preuss HG. Lowering the glycemic index of white bread using a white bean extract. Nutr J. 2009;8:52.

26. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev. 2004 Mar;9(1):63-9.

27. Celleno L, Tolaini MV, D’Amore A, Perricone NV, Preuss HG. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci. 2007;4(1):45-52.

28. Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med. 2007 Jul-Aug;13(4):32-7.

29. Chokshi D. Toxicity studies of Blockal, a dietary supplement containing Phase 2 Starch Neutralizer (Phase 2), a standardized extract of the common white kidney bean (Phaseolus vulgaris). Int J Toxicol. 2006 Sep-Oct;25(5):361-71.

30. Deglaire A, Moughan PJ, Bos C, Tome D. Commercial Phaseolus vulgaris extract (starch stopper) increases ileal endogenous amino acid and crude protein losses in the growing rat. J Agric Food Chem. 2006 Jul 12;54(14):5197-202.

31. Omoruyi F, Adamson I. Digestive and hepatic enzymes in streptozotocin-induced diabetic rats fed supplements of dikanut (Irvingia gabonensis) and cellulose. Ann Nutr Metab. 1993;37(1):14-23.

32. Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme. 1986;36(3):212-5.

33. Adamson I, Okafor C, Abu-Bakare A. A supplement of Dikanut (Irvingia gabonesis) improves treatment of type II diabetics. West Afr J Med. 1990 Apr-Jun;9(2):108-15.

34. Ngondi JL, Oben JE, Minka SR. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids Health Dis. 2005;4:12.

35. Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008;7:12.

36. Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009;8:7.

37. Oben JE, Ngondi JL, Blum K. Inhibition of Irvingia gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up-regulation of the adiponectin gene. Lipids Health Dis. 2008;7:44.

38. Cetinalp-Demircan P, Bekpinar S, Gurdol F, Orhan Y. Adiponectin is a link among inflammation, insulin resistance, and high-density lipoprotein cholesterol but is not associated with paraoxonase activity in premenopausal women. J Clin Hypertens (Greenwich). 2009 Nov;11(11):672-7.

39. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr). 2009 Nov 11.

40. Stenholm S, Koster A, Alley DE, et al. Adipocytokines and the metabolic syndrome among older persons with and without obesity - the InCHIANTI Study. Clin Endocrinol (Oxf). 2009 Oct 31.

41. Iwai K. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice. Plant Foods Hum Nutr. 2008 Dec;63(4):163-9.

42. Lamela M, Anca J, Villar R, Otero J, Calleja JM. Hypoglycemic activity of several seaweed extracts. J Ethnopharmacol. 1989 Nov;27(1-2):35-43.

43. Zhang J, Tiller C, Shen J, et al. Antidiabetic properties of polysaccharide- and polyphenolic-enriched fractions from the brown seaweed Ascophyllum nodosum. Can J Physiol Pharmacol. 2007 Nov;85(11):1116-23.

44. InnoVactiv, Inc. Data on file.

45. Available at: Accessed December 2, 2009.

46. Stulc T, Cecka R. Lipid-lowering treatment in metabolic syndrome. Vnitr Lek. 2009 Jul-Aug;55(7-8):626-30.

47. Andel M, Polák J, Kraml P, Dlouhý P, Stich V. Chronic mild inflammation links obesity, metabolic syndrome, atherosclerosis and diabetes. Vnitr Lek. 2009 Jul-Aug;55(7-8):659-65.

48. Hano T, Nishio I. Treatment of hypertension in the patients with obesity. Nippon Rinsho. 2001 May;59(5):973-7.

49. Kopf D, Muhlen I, Kroning G, Sendzik I, Huschke B, Lehnert H. Insulin sensitivity and sodium excretion in normotensive off- spring and hypertensive patients. Metabolism. 2001 Aug;50(8):929-35.

50. Noda M, Matsuo T, Nagano-Tsuge H, et al. Involvement of angiotensin II in progression of renal injury in rats with genetic non- insulin-dependent diabetes mellitus (Wistar fatty rats). Jpn J Pharmacol. 2001 Apr;85(4):416-22.

51. Hegele RA. Premature atherosclerosis associated with monogenic insulin resistance. Circulation. 2001 May 8;103(18):2225-9.

52. Katz AS, Goff DC, Feldman SR. Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease. Dermatol Online J. 2000 Sep;6(1):1.

53. Kaaks R. Plasma insulin, IGF-I and breast cancer. Gynecol Obstet Fertil. 2001 Mar;29(3):185-91.

54. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001 Feb 2;84(3):417-22.

55. Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000 Feb;24(2):252-8.

56. Diepvens K, Westerterp K R, Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R77-85.

57. Di Pierro F, Menghi AB, Barreca A, Lucarelli M, Calandrelli A. Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Altern Med Rev. 2009 Jun;14(2):154-60.

58. Maki KC, Reeves MS, Farmer M, et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr. 2009 Feb;139(2):264-70.

59. Tsai CH, Chiu WC, Yang NC, Ouyang CM, Yen YH. A novel green tea meal replacement formula for weight loss among obese individuals: a randomized controlled clinica J Nutr Biochem. 2000 Jan;11(1):45-51.

60. Juhel C, Armand M, Pafumi Y, Rosier C, Vandermander J, Lairon D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. Int J Food Sci Nutr. 2009 Sep 7:1-9.